Company news

Acrux Limited news in 2025

Acrux Limited's news releases, calls and decks from 2025, newest first.

View company

Divestment of Prilocaine 2.5% and Lidocaine 2.5%, Cream

December 11, 2025

AGM Presentation and Address

November 24, 2025

Acrux receives $0.4m advance on FY26 R&D Tax Incentive

November 12, 2025

Received $3.04m RDTI rebate for FY25

September 3, 2025

Appendix 4E and Full Year Statutory Accounts FY25

August 28, 2025

Licensing partnership in Saudi Arabia for Dapsone 5%, Gel

July 30, 2025

Receipt of second advance for FY25 R&D Tax Incentive

July 2, 2025

Dapsone 7.5%, Gel launched in the United States

May 8, 2025

Acrux CEO and Managing Director appointment

May 6, 2025

Acrux receives $1.73m advance on FY25 R&D Tax Incentive

April 2, 2025

Investor Presentation February 2025

February 25, 2025

Appendix 4D and December 2024 Half Year Accounts

February 25, 2025

Acrux CEO announces plan to retire

February 6, 2025

Monthly Activities/Appendix 4C Cash Flow Report

January 29, 2025

Launch of 90 gram pack size of Dapsone 5%, Gel in US

January 15, 2025

Decks in 2025